Intrahepatic cholangiocarcinoma (ICC) is a rapidly progressing malignancy; only a minority of the tumours can be resected and the palliative regimens have shown limited success. The aim of this study ...

Bleeding events and eligibility requirements in studies evaluating an antiangiogenic agent in hepatocellular carcinoma (HCC). Background: Few effective treatments exist for unresectable hepatic ...

A nomogram to predict pathologic lymph node positivity in clinical stage I-II pancreatic adenocarcinoma. A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular ...

China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...